Evidence map›Paper›PMID 33525415›Full record

ArticleMolecules (Basel, Switzerland)2021

Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism.

Riadh Badraoui, Mohd Adnan, Fevzi Bardakci, Mousa M Alreshidi

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Chemical Composition ofMetabolites · 2022
    Article
  12. Physiological Responses of the BivalvesAnimals : an open access journal from MDPI · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Pharmacokinetics and Therapeutic Potential ofLife (Basel, Switzerland) · 2022
    Article
  17. Article
  18. Article
  19. Journal of personalized medicine · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Riadh BadraouiLaboratory of General Biology, Department of Biology, University of Ha'il, Ha'il 81451, Saudi Arabia.ORCID 0000-0001-9054-7744
Mohd AdnanLaboratory of General Biology, Department of Biology, University of Ha'il, Ha'il 81451, Saudi Arabia.ORCID 0000-0002-7080-6822
Fevzi BardakciLaboratory of General Biology, Department of Biology, University of Ha'il, Ha'il 81451, Saudi Arabia.
Mousa M AlreshidiLaboratory of General Biology, Department of Biology, University of Ha'il, Ha'il 81451, Saudi Arabia.ORCID 0000-0002-3763-9698
University of Ha'il · SATunis University · TN

Funding

University of Hail - Deanship of Scientific Research COVID-1942
6 · The paper itself

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection inducing coronavirus disease 2019 (COVID-19) is still an ongoing challenge. To date, more than 95.4 million have been infected and more than two million deaths have been officially reported by the WHO. Angiotensin-converting enzyme (ACE) plays a key role in the disease pathogenesis. In this computational study, seventeen coding variants were found to be important for ACE2 binding with the coronavirus spike protein. The frequencies of these allele variants range from 3.88 × 10

Indexed as

Angiotensin-Converting Enzyme 2Molecular Docking SimulationPolymorphism, GeneticSARS-CoV-2Spike Glycoprotein, CoronavirusChloroquineCOVID-19COVID-19 Drug TreatmentHumansHydroxychloroquineProtein DomainsACE2 protein, humanAngiotensin-Converting Enzyme 2ChloroquineHydroxychloroquineSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2ACE2 allelic variantsbinding domainchloroquinecoronavirushydroxychloroquinein silicomolecular dockingmolecular interactions

Identifiers

PMID33525415
PMCPMC7865913
OpenAlexW3122941187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.